SkyQuest Technology Group recently introduced Digital Pathology Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Digital Pathology Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Global Digital Pathology Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.97 billion in 2024 to USD 1.77 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).
A computer-enabled image-based information platform called “digital pathology” aids in the administration of data produced from digital slides. The rise in cancer incidence, the need for precise diagnosis, and the creation of innovative digital pathology systems by numerous significant players are the main factors propelling the growth of the global digital pathology market Size. A survey released by Medscape suggests that a higher death rate may be linked to chronic illnesses. The increased frequency of cardiovascular illnesses is the primary driver behind the development of sophisticated diagnostic tools. Therefore, the requirement for digital pathology systems grows along with the development of chronic and cardiovascular diseases, propelling the growth of the digital pathology market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/digital-pathology-market
Technology in digital pathology can benefit a research pipeline in two ways. The first is that macroscopic photographs, tissue microarrays, and whole slide images can be arranged using the designated file storage and viewing software. The creation and use of image analysis methods is the second way that digital pathology is used in research. Additionally, government financing, the expanding use of telepathology solutions in drug development and companion diagnostics, as well as the growing demand for telepathology solutions, which enable pathologists to assess cases remotely and consult worldwide in real-time, are the primary drivers of digital pathology market expansion.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Digital Pathology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Product
Scanners (Brightfield Scanners, Fluorescence Scanners, Other Scanners), Software (Integarted Software, Standone Software), Deployment Model (Cloud-Based Model, On-Premise Model, Hybrid Model), Storage System
Type
Human Pathology, Veterinary Pathology
Application
Drug Discovery & Development, Academic Research, Disease Diagnosis (Cancer Cell Detection, Others)
End-use
Hospitals, Biotech & Pharma Companies, Diagnostic Labs, Academic & Research Institutes
Digital Pathology Market – Regional Analysis:
– Digital Pathology North America Market includes (Canada, Mexico, USA)
– Digital Pathology Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Digital Pathology Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Digital Pathology South America Market includes (Brazil, Argentina)
– Digital Pathology Oceania Market (Australia & New Zealand)
Top Market Players in Digital Pathology Market are:
Koninklijke Philips N.V. (Netherlands)
F. Hoffmann-La Roche Ltd (Switzerland)
Hamamatsu Photonics K.K. (Japan)
Olympus Corporation (Japan)
PerkinElmer, Inc. (United States)
3DHISTECH Ltd. (Hungary)
Sectra AB (Sweden)
Visiopharm A/S (Denmark)
Apollo Enterprise Imaging Corporation (Canada)
Corista LLC (United States)
Paige.AI, Inc. (United States)
Ibex Medical Analytics Ltd. (Israel)
Indica Labs, Inc. (United States)
Proscia Inc. (United States)
Deep Lens Inc. (United States)
Aiforia Technologies Oyj (Finland)
OptraSCAN, Inc. (United States)
Mikroscan Technologies, Inc. (United States)
Xilis, Inc. (United States)
Also Read –
https://www.openpr.com/news/3950512/how-is-biosimulation-revolutionizing-drug-development
https://pando.life/article/831065
Forward-Looking Insights
The Digital Pathology Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
